News | AgPlus Diagnostics

The Simultaneous Detection of Two Analytes on the Agilis System Using Silver and Gold Nanoparticles

Ag Plus release new white paper - This piece of work has shown that dual detection system for two different analytes can be accomplished on the AgPlus system using differing AuNP and AgNP simultaneously.

Job Vacancy – Production Technician

We are currently looking to employ a full-time production technician to support the manufacturing and R&D team within AgPlus.

CEO End of Year 2019 Round Up

What a year 2019 was for AgPlus, we have made significant progress this year on our Point of Care device.

Meet the Team: Holly Phillips

Meet Holly Phillips, the next featured member of our deeply passionate team here at AgPlus. As a Senior Production Development Scientist, Holly talks in more depth about her role within the company and the exciting year ahead.

AgPlus exhibits at MEDICA for first time.

Extremely positive feedback from the attendees of Medica 2019 for our Agilis Reader.

AgPlus Diagnostics wins a UKI2S Innovate Accelerator Fund

AgPlus is delighted to be the recipient of the UKI2S/ Innovate Fund. The grant will allow us to push through the final stages of clinical validation and commercialisation of our Point of Care Agilis Reader Platform.

Meet the Team: Catherine Adams

We are keen to introduce you to a different member of our deeply passionate team at AgPlus each month, to share the passion and dedication that is put into our business every day. Second in our 'Meet the Team' series is Catherine Adams, a research and development scientist.

Meet the Team: Dave Yallop

We are proud to have deeply passionate team at AgPlus. Now that our new website is live we would like to take this opportunity to introduce you to a different member of our team each month, to share the passion and dedication that is put into our business every day.

October CEO Update: 2 Years of Significant Progress

It was the exciting new technology at AgPlus that attracted me to join the business in 2018. I could immediately see the potential to commercialise this point of care device to the benefit of patients and healthcare providers through faster, cost-effective diagnosis.